MedPath
NMPA Approval

Inotuzumab Ozogamicin for Injection

国药准字SJ20210033

December 20, 2021

Drug Information

注射用奥加伊妥珠单抗

贝博萨

注射剂

1.0 mg/瓶

生物制品

December 20, 2021

December 19, 2026

Company Information

Applicant Company

P.O. Box 8299, Philadelphia, PA 19101, United States of America

Manufacturing Company

wyeth pharmaceutical division of wyeth holdings llc

401 North Middletown Road, Pearl River, NY 10965, United States of America

© Copyright 2025. All Rights Reserved by MedPath